These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23597406)

  • 1. The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors.
    Deford-Watts LM; Mintz A; Kridel SJ
    Curr Pharm Biotechnol; 2013; 14(3):300-12. PubMed ID: 23597406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
    Vāvere AL; Kridel SJ; Wheeler FB; Lewis JS
    J Nucl Med; 2008 Feb; 49(2):327-34. PubMed ID: 18199615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
    Yun M; Bang SH; Kim JW; Park JY; Kim KS; Lee JD
    J Nucl Med; 2009 Aug; 50(8):1222-8. PubMed ID: 19617323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of R-2-[
    Zhang Z; Liu S; Ma H; Nie D; Wen F; Zhao J; Sun A; Yuan G; Su S; Xiang X; Hu P; Tang G
    Mol Imaging Biol; 2019 Dec; 21(6):1127-1137. PubMed ID: 30847820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application.
    Yoshii Y; Furukawa T; Saga T; Fujibayashi Y
    Cancer Lett; 2015 Jan; 356(2 Pt A):211-6. PubMed ID: 24569091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of 11C-acetate PET/CT for imaging of fatty acid synthesis in the atherosclerotic vessel wall.
    Derlin T; Habermann CR; Lengyel Z; Busch JD; Wisotzki C; Mester J; Pávics L
    J Nucl Med; 2011 Dec; 52(12):1848-54. PubMed ID: 22065877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysis.
    Kwee SA; Lim J
    World J Radiol; 2016 Nov; 8(11):851-856. PubMed ID: 27928466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.
    Zaidi N; Lupien L; Kuemmerle NB; Kinlaw WB; Swinnen JV; Smans K
    Prog Lipid Res; 2013 Oct; 52(4):585-9. PubMed ID: 24001676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging tumor metabolism using positron emission tomography.
    Lewis DY; Soloviev D; Brindle KM
    Cancer J; 2015; 21(2):129-36. PubMed ID: 25815854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioneering and fundamental achievements on the development of positron emission tomography (PET) in oncology.
    Fukuda H; Kubota K; Matsuzawa T
    Tohoku J Exp Med; 2013 Jul; 230(3):155-69. PubMed ID: 23883588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
    Mena E; Turkbey B; Mani H; Adler S; Valera VA; Bernardo M; Shah V; Pohida T; McKinney Y; Kwarteng G; Daar D; Lindenberg ML; Eclarinal P; Wade R; Linehan WM; Merino MJ; Pinto PA; Choyke PL; Kurdziel KA
    J Nucl Med; 2012 Apr; 53(4):538-45. PubMed ID: 22343504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of lipogenic enzymes as a potential therapy against cancer.
    Montesdeoca N; López M; Ariza X; Herrero L; Makowski K
    FASEB J; 2020 Sep; 34(9):11355-11381. PubMed ID: 32761847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of metabolic PET imaging in radiation oncology.
    Zhu A; Marcus DM; Shu HK; Shim H
    Radiat Res; 2012 Apr; 177(4):436-48. PubMed ID: 22339451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.
    Leisser A; Pruscha K; Ubl P; Wadsak W; Mayerhöfer M; Mitterhauser M; Hacker M; Kramer G; Shariat S; Karanikas G; Hartenbach M; Haug AR
    Prostate; 2015 Nov; 75(15):1760-7. PubMed ID: 26282590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
    Lee M; Ko H; Yun M
    Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
    Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of
    Ayubcha C; Hosoya H; Seraj SM; Zadeh MZ; Werner T; Alavi A
    Hell J Nucl Med; 2019; 22(1):4-5. PubMed ID: 30843002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive evaluation of fat-carbohydrate metabolic switching in heart and contracting skeletal muscle.
    DeGrado TR; Pandey MK; Belanger AP; Basuli F; Bansal A; Wang S
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E251-E259. PubMed ID: 30512988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.